Parkwalk Advisors
PA
PA
Parkwalk Advisors
About
Key facts
- Portfolio companies
- 12
- Stages
- SeedSeries ASeries BSeries C
- Cheque size
- $2M to $55M
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 26 Oct 2026 | adsilico | Series A | $13M |
| 1 Jul 2026 | Moa Technology | Series C | $28M |
| 30 Mar 2026 | Semarion | Funding Round | $4M |
| 2 Sept 2025 | Cyted Health | Series B | $55M |
| 2 Sept 2025 | Phasecraft | Series B | $34M |
| 25 Aug 2025 | Paragraf | Series C | $55M |
| 27 Feb 2024 | Phasecraft | Series B | $31M |
| 26 Feb 2024 | adsilico | Seed | $4M |
| 17 May 2022 | Congenica | Undisclosed round | $50M |
| 28 Jan 2020 | Congenica | Undisclosed round | $14M |
Write the first review
Frequently asked
What companies has Parkwalk Advisors invested in?
Parkwalk Advisors has invested in adsilico, Moa Technology, Semarion, Cyted Health, Phasecraft and 7 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for Parkwalk Advisors:

